The prognosis of recurrent epithelial ovarian cancer is extremely poor. It is impossible to live more than 5 years when women had recurrent epithelial ovarian cancers. provide little chance to survive. We used the "metronomic therapy" strategy in the effectively prolonged the survival of a patient with recurrent epithelial ovarian cancer. After Chemotherapy is a main therapy, regardless of recurrence, this patient had a more than 10-year repeat surgery status. However, both strategies survival.